An economic evaluation of Tomudex (realtitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8e90eda6184e4176bad4d9691d3caa2f,

title = "An economic evaluation of Tomudex (realtitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer",

author = "MGH Groener and \{van Ineveld\}, Martin and G Byttebier and \{van Hout\}, \{BA (Ben)\}",

year = "1999",

doi = "10.1097/00001813-199903000-00005",

language = "Undefined/Unknown",

volume = "10",

pages = "283--288",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams \& Wilkins",

}

TY - JOUR

T1 - An economic evaluation of Tomudex (realtitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer

AU - Groener, MGH

AU - van Ineveld, Martin

AU - Byttebier, G

AU - van Hout, BA (Ben)

PY - 1999

Y1 - 1999

U2 - 10.1097/00001813-199903000-00005

DO - 10.1097/00001813-199903000-00005

M3 - Article

SN - 0959-4973

VL - 10

SP - 283

EP - 288

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -